Differential treatment responses to immune checkpoint inhibitor (ICI) therapy in a case of multiple primary malignancies: the programmed death ligand-1 (PD-L1) negative ureteral and lung metastasis from a clear cell renal cell carcinoma appearing after robotic-assisted partial nephrectomy progressed after ICI therapy, while synchronous PD-L1-positive primary lung squamous cell carcinoma responded very well to ICI therapy: a case report

Masayasu Urushibara, Kazuhiro Ishizaka, Noriyuki Matsutani, Mikiko Takahashi, Masakazu Nagata, Taisuke Okumura, Yuuki Matsumoto, Shinichiro Tatsuoka, Tsunehiro Nenohi, Takumasa Amemiya, Yohei Shimizu, Takeshi Shirakawa, Daisuke Kato

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Differential treatment responses to immune checkpoint inhibitor (ICI) therapy in a case of multiple primary malignancies: the programmed death ligand-1 (PD-L1) negative ureteral and lung metastasis from a clear cell renal cell carcinoma appearing after robotic-assisted partial nephrectomy progressed after ICI therapy, while synchronous PD-L1-positive primary lung squamous cell carcinoma responded very well to ICI therapy: a case report'. Together they form a unique fingerprint.

Medicine and Dentistry